Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 6/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | RARA | P10276 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | MTOR | P42345 | 1/20 | 0.60 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.52 |
| ▸ | RXRA | P19793 | 1/20 | 0.51 |
| ▸ | RXRB | P28702 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.48 |
| ▸ | BCL2 | P10415 | 1/20 | 0.47 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1058497 | 0.94 | ALDH1A1 (0.67) | RARBALDH1A1KMT2AMEN1RARA | |
| SCHEMBL8260837 | 0.85 | ALDH1A1 (0.77) | ALDH1A1MAPTFFAR1 | |
| SCHEMBL14066552 | 0.85 | FFAR1 (0.71) | ALDH1A1FFAR1RXRARXRBHSD17B10 | |
| SCHEMBL6370196 | 0.84 | ALDH1A1 (0.53) | RARBALDH1A1KMT2AMEN1RARA | |
| SCHEMBL1613991 | 0.83 | HSD17B10 (0.62) | RARBALDH1A1KMT2AMEN1RARA | |
| SCHEMBL12126626 | 0.82 | ALDH1A1 (0.61) | RARBALDH1A1MAPTFFAR1RXRA | |
| Terephthalic Acid SCHEMBL28210383 | 0.82 | RARB (0.69) | RARBALDH1A1KMT2AMEN1RARA | |
| SCHEMBL10912165 | 0.82 | ALDH1A1 (0.77) | ALDH1A1MAPTFFAR1HSD17B10 | |
| SCHEMBL200372 | 0.81 | RARB (0.79) | RARBALDH1A1KMT2AMEN1RARA | |
| SCHEMBL4571014 | 0.80 | NR1H4 (0.64) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11802258-B2 | Perfume precursor | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2023-10-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11802258-B2 | Perfume precursor | CYP2E1, ADH1A, CYP1A1 | RARB 2669/4885ALDH1A1 26/4885KMT2A 2414/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.